海外の治験の状況「1」での検索結果
185件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Phase 1, open label, repeat-dose, dose escalation study of the safety and tolerability of Staphylococcal protein A in adult patients with chronic Idiopathic Thrombocytopenic Purpura (ITP)
- Idiopathic Thrombocytopenic Purpura
- Australia, New Zealand
- 2007-08-24
Recruiting
- A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy
- Crohn's Disease
- American Samoa, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-11-15
Recruiting
- A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy
- Crohn's Disease
- American Samoa, Argentina, Australia, Austria, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Egypt, Estonia, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2017-11-15
Recruiting
- PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
- Carcinoma, Basal Cell
- Austria, Belgium, Canada, France, Germany, Greece, Italy, Spain, Switzerland, United States
- 2017-04-24
Recruiting
- A Research Study of How Overdosing of a New Once Weekly Medicine NNC0148-0287 C (Insulin 287) Influences the Blood Sugar Level in People With Type 2 Diabetes
- Diabetes Mellitus, Type 2
- Austria
- 2019-05-08
Recruiting
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- B Acute Lymphoblastic Leukemia;BCR-ABL1 Fusion Protein Expression;Minimal Residual Disease;Philadelphia Chromosome Positive;T Acute Lymphoblastic Leukemia;Untreated Adult Acute Lymphoblastic Leukemia;Untreated Childhood Acute Lymphoblastic Leukemia
- Australia, Austria, Canada, Chile, China, Czechia, France, Germany, Italy, Netherlands, New Zealand, Puerto Rico, Saudi Arabia, Sweden, United Kingdom, United States
- 2016-12-28
Recruiting
- A Phase 1/2 Study of Valproate in Combination with Interferon alpha in Relapsed, Recurrent or Progressive Neuroblastoma
- Relapsed, Recurrent or Progressive Neuroblastoma
- Australia, New Zealand
- 2010-10-06
Recruiting
- A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks
- Lung Cancer;C34 - Malignant neoplasm of bronchus and lung
- Australia, Austria, Canada, France, Germany, Italy, Spain, United States
- 2017-02-02
Recruiting
- Insulin signal peptide, a novel measure of pancreatic insulin synthesis and production
- diabetes mellitus;Insulin signal peptide, a novel measure of pancreatic insulin synthesis and production
- New Zealand
- 2012-11-14
Recruiting
- International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
- ;C91 - Lymphoid leukaemia
- Australia, Austria, Chile, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Israel, Italy, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, United Kingdom, United States
- 2019-05-14